je.st
news
Tag: phase
First patient in IdeS phase II study transplanted
2015-06-15 18:05:49| Appliances - Topix.net
Hansa Medical AB today announced that the first patient after treatment with IdeS in a recently initiated Phase II study has been transplanted from a deceased donor. The phase II study that can include up to 10 patients is performed at Uppsala University Hospital and Karolinska University Hospital.
Tags: study
phase
patient
ides
G P Zachariades secures Bahrain International Airports second phase expansion contract
2015-06-15 01:00:00| Airport Technology
G P Zachariades Engineering and Construction has received a contract for the second phase of expansion of the Bahrain International Airport (BIA).
Tags: international
contract
phase
expansion
Curtiss-Wright Completes Development Phase of Contract from LIG Nex1 to Support Next-Generation Radar Programs
2015-06-12 12:31:11| Industrial Newsroom - All News for Today
For FPGA-based OpenVPX Processing Modules used in Korean Armys Next-Generation Local Air Defense Radar and Air Force Long-Range Surveillance Radar Programs ASHBURN, Va. Curtiss-Wright Corporation (NYSE: CW) today announced that its Defense Solutions division has completed the development phase of a contract...
Tags: support
development
programs
contract
Pacritinib Phase 3 Study Shows Positive Results In Patient Reported...
2015-06-12 11:30:00| Logistics - Topix.net
As recently reported at the American Society of Clinical Oncology annual meeting, results show a significant reduction in the Total Symptom Score , and in each individual common disease-related symptom, from baseline to Week 24, in patients treated with pacritinib compared to best available therapy . These PROs, as well as other quality of life measures, will be presented at the 20th Congress of European Hematology Association by .
Tags: results
study
shows
positive
Merck and Samsung Bioepis Announce Pivotal Phase 3 Studies for Investigational Biosimilars SB4, Enbrel (Etanercept), and SB2, Remicade (Infliximab), Met Primary Endpoints
2015-06-10 14:46:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. & SEOUL, South Korea Data Presented for the First Time at the EULAR Annual Meeting Phase 1 Data for SB2, SB4 and SB5, an Investigational Biosimilar of Humira (Adalimumab), also Presented KENILWORTH, N.J. & SEOUL, South Korea--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced that pivotal Phase 3 clinical studies of SB4, an investigational biosimilar of Enbrel (etanercept), and SB2, an investigational biosimilar of Remicade (infliximab), met their primary endpoints, demonstrating equivalence to the originator medicine in patients with moderate to severe rheumatoid arthritis (RA) despite methotrexate therapy. Language: English Contact: Merck Media:Pamela Eisele, 267-305-3558Robert Consalvo, 908-236-1127orMerck Investors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879orSamsung Bioepis Media:Jamyung Cha, (82) 32-455-6137orSamsung Bioepis Investors:Sungjoon Park, (82) 32-455-6120 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: met
primary
studies
phase
Sites : [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] next »